Site Selection, Pre-Trial Visit, Site Evaluation, Site Qualification... Whatever terminology your company uses, it is arguably the most important visit of any study.
Selecting the right investigators for your clinical trial is key to a successful outcome. Despite the fact that Western European countries remain important centres for conducting clinical trials, approximately 35% of delay in studies is due to slower than planned patient recruitment, with roughly 20% of clinical trial sites not enrolling any patients and about one-third enrolling only 5% of evaluable patients. That's why getting it right at the selection stage is so important.
At Stonebridge Clinical, Investigator Site selection is what we specialise in. We provide a service to CROs and Pharmaceutical companies alike, potentially freeing up existing experienced resource and expertise to cover the monitoring of ongoing and new studies.
Whether it is the last minute Site Selection visit you need covered to meet a sponsor milestone or regulatory submission deadline for your project, or even a full list of selection visits across the country, we can help you meet that deadline.
Offering a flexible service to all companies both large and small CROs, Pharmaceutical or Biotech companies - whether you want a commitment to cover your Site Selection activities over a certain period or just when you need cover, for when you have a sudden peak in selection activity for example or monitoring a study from Site Initiation to Site Closeout.